GLP-1 Injections Win Over Wellness Pioneer, Boost Market Despite Spa Challenges
Michelle Kelsch, co-founder of Movara Wellness Resort, has warmed up to GLP-1 news injections after personally experiencing their effectiveness. Despite initial skepticism, she now sees them as aligning with her long-standing approach to wellness. Meanwhile, destination spas like Hilton Head Health (H3) have weathered a dip in new guest arrivals, thanks to marketing efforts and new programs.
The global wellness market, valued at US$6.3 trillion, has felt the impact of GLP-1s. These injections have gained popularity, even leading to challenges for destination spas five years after their peak. Kelsch, who was initially dismissive of diet trends, changed her tune after losing nine kilograms in a few months using a GLP-1 injection. She now believes they fit well with her philosophy of exercise, discipline, and calorie management.
H3, for instance, experienced a dip in new guest arrivals in 2023. However, the resort bounced back in 2024 by ramping up marketing efforts and introducing new programs. This turnaround demonstrates the resilience of these wellness destinations in the face of changing news.
GLP-1 weight loss injections have made a significant impact on the wellness market, even challenging traditional destination spas. Michelle Kelsch, once skeptical, now endorses these injections as a tool for wellness. Despite initial setbacks, wellness resorts like H3 have shown adaptability, recovering through innovative strategies.
